These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 16836556

  • 1. Acute and long-term effects of modified hemoglobin (HBOC-201) in a rat model of hypertension and chronic kidney disease.
    Baylis C.
    Transfusion; 2006 Jul; 46(7):1104-11. PubMed ID: 16836556
    [Abstract] [Full Text] [Related]

  • 2. A re-evaluation of the renal ablation model of progressive renal disease in rats.
    Kim KH, Kim Y, Park HW, Jeong HJ, Mauer M.
    J Nephrol; 2003 Jul; 16(2):196-202. PubMed ID: 12768066
    [Abstract] [Full Text] [Related]

  • 3. The mTOR inhibitor everolimus induces proteinuria and renal deterioration in the remnant kidney model in the rat.
    Vogelbacher R, Wittmann S, Braun A, Daniel C, Hugo C.
    Transplantation; 2007 Dec 15; 84(11):1492-9. PubMed ID: 18091526
    [Abstract] [Full Text] [Related]

  • 4. Regional blood flow after serial normovolemic exchange transfusion with HBOC-201 (Hemopure) in anesthetized swine.
    Mongan PD, Moon-Massat PF, Rentko V, Mihok S, Dragovich A, Sharma P.
    J Trauma; 2009 Jul 15; 67(1):51-60. PubMed ID: 19590308
    [Abstract] [Full Text] [Related]

  • 5. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R.
    Nefrologia; 2008 Jul 15; 28 Suppl 3():87-93. PubMed ID: 19018744
    [Abstract] [Full Text] [Related]

  • 6. Profiling biochemical and hemodynamic markers using chronically instrumented, conscious and unrestrained rats undergoing severe, acute controlled hemorrhagic hypovolemic shock as an integrated in-vivo model system to assess new blood substitutes.
    Daull P, Blouin A, Cayer J, Beaudoin M, Belleville K, Sirois P, Nantel F, Chang TM, Battistini B.
    Vascul Pharmacol; 2005 Oct 15; 43(4):289-301. PubMed ID: 16253569
    [Abstract] [Full Text] [Related]

  • 7. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.
    Minutolo R, Gabbai FB, Borrelli S, Scigliano R, Trucillo P, Baldanza D, Laurino S, Mascia S, Conte G, De Nicola L.
    Am J Kidney Dis; 2007 Dec 15; 50(6):908-17. PubMed ID: 18037091
    [Abstract] [Full Text] [Related]

  • 8. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A, Goicoechea Diezhandiño M, de Alvaro Moreno F.
    Nefrologia; 2008 Dec 15; 28 Suppl 3():39-48. PubMed ID: 19018737
    [Abstract] [Full Text] [Related]

  • 9. Combination of exercise and enalapril enhances renoprotective and peripheral effects in rats with renal ablation.
    Kanazawa M, Kawamura T, Li L, Sasaki Y, Matsumoto K, Kataoka H, Ito O, Minami N, Sato T, Ootaka T, Kohzuki M.
    Am J Hypertens; 2006 Jan 15; 19(1):80-6. PubMed ID: 16461196
    [Abstract] [Full Text] [Related]

  • 10. Antiproteinuric and blood pressure-lowering effects of a fixed-dose combination of losartan and hydrochlorothiazide in hypertensive patients with stage 3 chronic kidney disease.
    Abe M, Okada K, Maruyama T, Matsumoto K.
    Pharmacotherapy; 2009 Sep 15; 29(9):1061-72. PubMed ID: 19698011
    [Abstract] [Full Text] [Related]

  • 11. Effect of clonidine on the progression of chronic renal disease in partially nephrectomized rats.
    Wilke WL, Fettman MJ, Tan AA.
    Res Commun Chem Pathol Pharmacol; 1987 Aug 15; 57(2):161-72. PubMed ID: 2821594
    [Abstract] [Full Text] [Related]

  • 12. GFR, proteinuria and circadian blood pressure.
    Agarwal R, Light RP.
    Nephrol Dial Transplant; 2009 Aug 15; 24(8):2400-6. PubMed ID: 19251741
    [Abstract] [Full Text] [Related]

  • 13. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
    Esnault VL, Brown EA, Apetrei E, Bagon J, Calvo C, DeChatel R, Holdaas H, Krcmery S, Kobalava Z, Amlodipine Versus Enalapril in Renal failure (AVER) Study Group.
    Clin Ther; 2008 Mar 15; 30(3):482-98. PubMed ID: 18405787
    [Abstract] [Full Text] [Related]

  • 14. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS, Bishu K, Rector TS, Ishani A, Kuskowski MA, Cohn JN.
    Circulation; 2009 Oct 20; 120(16):1577-84. PubMed ID: 19805651
    [Abstract] [Full Text] [Related]

  • 15. Bovine hemoglobin-based oxygen-carrying solution (HBOC-201) improves flap survival in a rat model of epigastric flap failure.
    Ortegon DP, Davis MR, Sampson JB, Dick EJ, Kashyap V, Kerby JD.
    Microsurgery; 2006 Oct 20; 26(3):203-6. PubMed ID: 16493668
    [Abstract] [Full Text] [Related]

  • 16. Management and control of hypertension and proteinuria in patients with advanced chronic kidney disease under nephrologist care or not: data from the AVENIR study (AVantagE de la Nephroprotection dans l'Insuffisance Renale).
    Thilly N, Boini S, Kessler M, Briançon S, Frimat L.
    Nephrol Dial Transplant; 2009 Mar 20; 24(3):934-9. PubMed ID: 19001561
    [Abstract] [Full Text] [Related]

  • 17. Hemoglobin-based oxygen carrying compound-201 as salvage therapy for severe neuro- and polytrauma (Injury Severity Score = 27-41).
    Dudkiewicz M, Harpaul TA, Proctor KG.
    Crit Care Med; 2008 Oct 20; 36(10):2838-48. PubMed ID: 18766094
    [Abstract] [Full Text] [Related]

  • 18. Short- and long-term follow-up of glomerular and tubular renal markers of kidney function in hyperthyroid cats after treatment with radioiodine.
    van Hoek I, Lefebvre HP, Peremans K, Meyer E, Croubels S, Vandermeulen E, Kooistra H, Saunders JH, Binst D, Daminet S.
    Domest Anim Endocrinol; 2009 Jan 20; 36(1):45-56. PubMed ID: 19010632
    [Abstract] [Full Text] [Related]

  • 19. Hematology patterns after hemoglobin-based oxygen carrier resuscitation from severe controlled hemorrhage with prolonged delayed definitive care.
    Arnaud F, Fasipe D, Philbin N, Rice J, Flournoy WS, Ahlers S, McCarron R, Freilich D.
    Transfusion; 2007 Nov 20; 47(11):2098-109. PubMed ID: 17958540
    [Abstract] [Full Text] [Related]

  • 20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 20; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.